Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Exenatide Synthetic

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    AstraZeneca`s Byetta Receives Approval in US
    AstraZeneca`s Byetta Receives Approval in US

    01 Nov 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021773

    FDA
    01 Nov 2024
    Share Share
    From injections to pills: FDA approves first oral GLP-1 for type 2 diabetes
    From injections to pills: FDA approves first oral GLP-1 for type 2 diabetes

    09 Oct 2019

    // Allie Nawrat PHARMACEUTICAL TECHNOLOGY

    https://www.pharmaceutical-technology.com/features/first-oral-glp-1-type-2-diabetes/

    Allie Nawrat PHARMACEUTICAL TECHNOLOGY
    09 Oct 2019
    Share Share
    Eli Lilly picks up an oral GLP-1 diabetes drug from Roche sub for $50M
    Eli Lilly picks up an oral GLP-1 diabetes drug from Roche sub for $50M

    27 Sep 2018

    // John Carroll ENDPTS

    https://endpts.com/eli-lilly-picks-up-an-oral-glp-1-from-a-big-roche-sub-for-50m-in-cash-plus-deal-and-its-not-a-peptide/

    John Carroll ENDPTS
    27 Sep 2018
    Share Share
    ADA: Trulicity bests Victoza, Bydureon in real-world study
    ADA: Trulicity bests Victoza, Bydureon in real-world study

    25 Jun 2018

    // Eric Sagonowsky FIERCE PHARMA

    https://www.fiercepharma.com/ada-lilly-s-trulicity-bests-novo-s-victoza-az-s-bydureon-real-world-study

    Eric Sagonowsky FIERCE PHARMA
    25 Jun 2018
    Share Share
    AstraZeneca’s once-weekly diabetes drug wins expanded FDA approval
    AstraZeneca’s once-weekly diabetes drug wins expanded FDA approval

    03 Apr 2018

    // Sarah Faulkner DRUGDELIVERY

    https://www.drugdeliverybusiness.com/astrazenecas-once-weekly-diabetes-drug-wins-expanded-fda-approval/

    Sarah Faulkner DRUGDELIVERY
    03 Apr 2018
    Share Share
    Novo gets FDA blessing for Type 2 diabetes drug Ozempic
    Novo gets FDA blessing for Type 2 diabetes drug Ozempic

    06 Dec 2017

    // E. Sagonowsky FIERCE PHARMA

    https://www.fiercepharma.com/regulatory/novo-wins-fda-blessing-for-ozempic-a-weekly-diabetes-med-carrying-big-expectations

    E. Sagonowsky FIERCE PHARMA
    06 Dec 2017
    Share Share